Edwards Lifesciences Forecasts Strong Grow... (

Edwards Lifesciences Forecasts Strong Growth in 2008

Date:12/7/2007

- EPS Growth of 11% to 14% Projected

- Expanded PARTNER Trial to Include Transapical System

- European Approval Received for Transapical System

NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today will provide investors with information on the initiatives expected to drive sales growth and profitability in 2008 and beyond. During its 2007 investor conference in New York City, Edwards' management will present details of the company's growth plans, market expansion opportunities and its financial outlook for 2008.

"We expect 2008 to be a very successful and important year for Edwards Lifesciences," said Michael A. Mussallem, chairman and CEO. "Our market-leading heart valve and critical care franchises provide a strong foundation for continued growth. We expect our strategic portfolio changes and sales of new products to drive greater profitability and grow earnings. Additionally, our market-expanding transcatheter valve technologies are expected to generate more than $20 million of sales next year."

During the conference, Edwards' management also will present the company's financial goals for 2008, including total sales between $1.16 billion to $1.21 billion, increasing gross profit margin by 100 to 150 basis points, delivering earnings per share growth of 11 to 14 percent, excluding the impact of special items, and generating free cash flow of $155 million to $165 million.
Among the specific topics to be discussed at today's event are:

-- Transcatheter Heart Valve Therapy -- Edwards continues to lead the

adv
'/>"/>

2

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
9. U-M research: New plastic is strong as steel, transparent
10. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
11. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results

Post Your Comments:

Edwards Lifesciences Forecasts Strong Grow...( - EPS Growth of 1...)